PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 65 filers reported holding PROVENTION BIO INC in Q1 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $41,753,395 | +26.8% | 1,732,506 | -44.4% | 0.00% | +100.0% |
| Q4 2022 | $32,941,152 | +465.5% | 3,116,476 | +140.8% | 0.00% | – |
| Q3 2022 | $5,825,000 | +20.4% | 1,294,425 | +7.0% | 0.00% | – |
| Q2 2022 | $4,837,000 | -48.2% | 1,209,189 | -5.1% | 0.00% | – |
| Q1 2022 | $9,331,000 | +36.9% | 1,274,666 | +5.1% | 0.00% | – |
| Q4 2021 | $6,815,000 | -25.3% | 1,212,710 | -14.9% | 0.00% | – |
| Q3 2021 | $9,125,000 | -18.5% | 1,425,738 | +7.3% | 0.00% | -100.0% |
| Q2 2021 | $11,198,000 | -1.7% | 1,328,337 | +22.4% | 0.00% | 0.0% |
| Q1 2021 | $11,393,000 | -32.5% | 1,085,609 | +9.0% | 0.00% | 0.0% |
| Q4 2020 | $16,872,000 | +27.3% | 995,965 | -3.6% | 0.00% | 0.0% |
| Q3 2020 | $13,256,000 | +8.5% | 1,033,239 | +19.4% | 0.00% | 0.0% |
| Q2 2020 | $12,214,000 | +6839.8% | 865,599 | +4431.9% | 0.00% | – |
| Q1 2020 | $176,000 | -48.1% | 19,100 | -16.0% | 0.00% | – |
| Q4 2019 | $339,000 | +189.7% | 22,730 | +32.9% | 0.00% | – |
| Q3 2019 | $117,000 | – | 17,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 14,879,023 | $157,271,273 | 9.67% |
| MPM BioImpact LLC | 898,483 | $9,496,965 | 2.46% |
| VR Adviser, LLC | 1,118,653 | $11,824,162 | 1.99% |
| Ghost Tree Capital, LLC | 400,000 | $4,228,000 | 1.80% |
| EAM Investors, LLC | 276,250 | $2,919,963 | 0.60% |
| EAM Global Investors LLC | 209,856 | $2,218,178 | 0.57% |
| 683 Capital Management, LLC | 550,000 | $5,813,500 | 0.49% |
| Palo Alto Investors LP | 390,800 | $4,130,756 | 0.35% |
| CABOT WEALTH MANAGEMENT INC | 184,271 | $1,948 | 0.33% |
| ADVISORY RESEARCH INC | 288,707 | $3,051,633 | 0.29% |